Weight Loss Jab 'Could Harm Those With Eating Disorders'

A newly approved weight-loss jab should be used with caution as it could be harmful to those vulnerable to eating disorders, doctors have warned.

- Rebecca Thomas

Thousands struggling with obesity could be prescribed a drug called semaglutide - sold under the brand name Wegovy - which scientists have described as a "game changer", after the National Institute for Health and Care Excellence (NICE) approved its use.

However, eating disorder experts have warned the NHS to proceed with caution in prescribing the drug, with one GP accusing NICE of being "absolutely reckless" in approving it.

The drug was approved yesterday for use in adults who have at least one weight-related condition, such as type 2 diabetes, high blood pressure, high-cholesterol sleep apnoea and heart disease, or a body mass index score of at least 35. It can only be prescribed to those undergoing weight management treatment.

Some scientists and clinicians have praised the decision. However, Edward Emond, head of services at the eating disorders charity Beat, said it was simply a short-term fix.

"Even with it being through prescription, this is presenting a drug as a 'quick fix' and is not really looking at the bigger picture on why somebody might be struggling with [weight] ... Generally, this approach is like a restrictive diet, and we know [that going] on a restrictive diet for a significant period is one of the biggest risk factors for developing an eating disorder.